Woodline Partners LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1784547 San Francisco, CA

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,599,314

-$352,201 QoQ

Shares Held

171,805

0.0% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,423,987,323 across 188 Biotechnology names. RARE ranks #126 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,599,314	171,805	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,951,515	171,805	-37.1%	Shares	Sole	2026-02-17
2025-09-30	$8,219,390	273,251	0.0%	Shares	Sole	2025-11-14
2025-06-30	$9,935,406	273,251	+1.8%	Shares	Sole	2025-08-14
2025-03-31	$9,721,009	268,462	-0.4%	Shares	Sole	2025-05-15
2024-12-31	$11,340,220	269,556	+0.7%	Shares	Sole	2025-02-14
2024-09-30	$14,862,680	267,555	+0.3%	Shares	Sole	2024-11-14
2024-06-30	$10,965,069	266,790	-33.3%	Shares	Sole	2024-08-14
2024-03-31	$18,681,789	400,124	0.0%	Shares	Sole	2024-05-15
2023-12-31	$19,133,929	400,124	+94.7%	Shares	Sole	2024-02-14
2023-09-30	$7,325,468	205,483	-13.1%	Shares	Sole	2023-11-14
2023-06-30	$10,912,697	236,564	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.